The pharmaceutical sector continues to attract investor attention, with recent clinical developments highlighting the ...
Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 across the United States, European Union, Canada and Australia. These filings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback